As per the statistics published by The Lancet, approximately 2.4 million Indians die of treatable ailments annually. In 2020, about 151 thousand lives were lost to the pandemic alone, mainly due to the inadequate healthcare system coupled with the increasingly high population density. The reign of COVID-19 has highlighted the infirmities in existing healthcare services in several of the world’s advanced economies. For India, the pandemic serves as a clarion call to take top-priority action towards upgrading its public healthcare system.
Unprecedented times have demanded unprecedented budgets worldwide. The Government of India too has had to meet the pressure by stepping up its budgetary allocation towards healthcare and the pharma sector. This essential measure has propelled the Coronavirus vaccination drive, which has been keenly awaited by the country’s citizens.
Please click here to read the full article by Sidharrth Shankar and Aman Bhatia, published in Express Healthcare.
Sidharrth (Sid) is a seasoned corporate lawyer and also the co-chair of the corporate practice with a core focus on private equity and mergers & acquisitions. Sid has substantial experience advising global private equity funds, multinational corporations and strategic investors on complex cross-border transactions across a broad spectrum of industries over the last two and a half decades, with over two decades in JSA itself.